FcR-like 2 inhibition of B cell receptor-mediated activation of B cells

Journal of Immunology

Volumn 185, Issue 12, 2010, Pages 7405-7412

  Jackson, Tanisha A ^a   Haga, Christopher L ^e,f   Ehrhardt, Gotz R A ^e,f   Davis, Randall S ^a,b,c,d   Cooper, Max D ^e,f,g,h  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f EMORY UNIVERSITY   (United States)

^g EMORY CENTER FOR AIDS RESEARCH   (United States)

^h Georgia Research Alliance   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; FCR LIKE 2 PROTEIN; MEMBRANE PROTEIN; PROTEIN TYROSINE PHOSPHATASE SHP 1; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MEMORY CELL; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; AMINO ACID SUBSTITUTION; ANIMALS; B-LYMPHOCYTES; CELL LINE; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MICE; MUTATION; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 78650675626     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002305     Document Type: Article

References (37)

1. Hatzivassiliou, G., I. Miller, J. Takizawa, N. Palanisamy, P. H. Rao, S. Iida, S. Tagawa, M. Taniwaki, J. Russo, A. Neri, et al. 2001. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 14:277-289.
2. Davis, R. S., Y. H. Wang, H. Kubagawa, and M. D. Cooper. 2001. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc. Natl. Acad. Sci. USA 98:9772-9777.
3. Xu, M. J., R. Zhao, and Z. J. Zhao. 2001. Molecular cloning and characterization of SPAP1, an inhibitory receptor. Biochem. Biophys. Res. Commun. 280:768-775.
4. Guselnikov, S. V., S. A. Ershova, L. V. Mechetina, A. M. Najakshin, O. Y. Volkova, B. Y. Alabyev, and A. V. Taranin. 2002. A family of highly diverse human and mouse genes structurally links leukocyte FcR, gp42 and PECAM-1. Immunogenetics 54:87-95.
5. Ehrhardt, G. R., and M. D. Cooper. 2010. Immunoregulatory roles for Fc receptor-like molecules. Curr. Top. Microbiol. Immunol. In press.
6. Miller, I., G. Hatzivassiliou, G. Cattoretti, C. Mendelsohn, and R. Dalla-Favera. 2002. IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells. Blood 99:2662-2669.
7. Nakayama, Y., S. M. Weissman, and A. L. Bothwell. 2001. BXMAS1 identifies a cluster of homologous genes differentially expressed in B cells. Biochem. Biophys. Res. Commun. 285:830-837.
8. Ehrhardt, G. R., R. S. Davis, J. T. Hsu, C. M. Leu, A. Ehrhardt, and M. D. Cooper. 2003. The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc. Natl. Acad. Sci. USA 100:13489-13494.
9. Leu, C. M., R. S. Davis, L. A. Gartland, W. D. Fine, and M. D. Cooper. 2005. FcRH1: an activation coreceptor on human B cells. Blood 105:1121-1126.
10. Haga, C. L., G. R. Ehrhardt, R. J. Boohaker, R. S. Davis, and M. D. Cooper. 2007. Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment. Proc. Natl. Acad. Sci. USA 104:9770-9775.
11. Harwood, N. E., and F. D. Batista. 2010. Early events in B cell activation. Annu. Rev. Immunol. 28:185-210.
12. Gauld, S. B., J. M. Dal Porto, and J. C. Cambier. 2002. B cell antigen receptor signaling: roles in cell development and disease. Science 296:1641-1642.
13. Dal Porto, J. M., S. B. Gauld, K. T. Merrell, D. Mills, A. E. Pugh-Bernard, and J. Cambier. 2004. B cell antigen receptor signaling 101. Mol. Immunol. 41:599-613.
14. Clark, M. R., K. S. Campbell, A. Kazlauskas, S. A. Johnson, M. Hertz, T. A. Potter, C. Pleiman, and J. C. Cambier. 1992. The B cell antigen receptor complex: association of Ig-alpha and Ig-beta with distinct cytoplasmic effectors. Science 258:123-126.
15. Ravetch, J. V., and S. Bolland. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19:275-290.
16. Ono, M., S. Bolland, P. Tempst, and J. V. Ravetch. 1996. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc (gamma) RIIB. Nature 383:263-266.
17. Cornall, R. J., J. G. Cyster, M. L. Hibbs, A. R. Dunn, K. L. Otipoby, E. A. Clark, and C. C. Goodnow. 1998. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8:497-508.
18. Adachi, T., H. Flaswinkel, H. Yakura, M. Reth, and T. Tsubata. 1998. The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. J. Immunol. 160:4662-4665.
19. Jackson, D. E. 2003. The unfolding tale of PECAM-1. FEBS Lett. 540:7-14.
20. Daëron, M., S. Jaeger, L. du Pasquier, and E. Vivier. 2008. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol. Rev. 224:11-43.
21. Kochi, Y., K. Myouzen, R. Yamada, A. Suzuki, T. Kurosaki, Y. Nakamura, and K. Yamamoto. 2009. FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J. Immunol. 183:5502-5510.
22. Hüttmann, A., L. Klein-Hitpass, J. Thomale, R. Deenen, A. Carpinteiro, H. Nückel, P. Ebeling, A. Führer, J. Edelmann, L. Sellmann, et al. 2006. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. Leukemia 20:1774-1782.
23. Underhill, D. M., and H. S. Goodridge. 2007. The many faces of ITAMs. Trends Immunol. 28:66-73.
24. Irish, J. M., D. K. Czerwinski, G. P. Nolan, and R. Levy. 2006. Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry. J. Immunol. 177:1581-1589.
25. Polson, A. G., B. Zheng, K. Elkins, W. Chang, C. Du, P. Dowd, L. Yen, C. Tan, J. A. Hongo, H. Koeppen, and A. Ebens. 2006. Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia. Int. Immunol. 18:1363-1373.
26. Poole, A. W., and M. L. Jones. 2005. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Cell. Signal. 17:1323-1332.
27. Ehrhardt, G. R., J. T. Hsu, L. Gartland, C. M. Leu, S. Zhang, R. S. Davis, and M. D. Cooper. 2005. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J. Exp. Med. 202:783-791.
28. Campbell, J. A., R. S. Davis, L. M. Lilly, D. H. Fremont, A. R. French, and L. N. Carayannopoulos. 2010. Cutting edge: FcR-like 5 on innate B cells is targeted by a poxvirus MHC class I-like immunoevasin. J. Immunol. 185:28-32.
29. Schreeder, D. M., J. P. Cannon, J. Wu, R. Li, M. A. Shakhmatov, and R. S. Davis. 2010. Cutting edge: FcR-like 6 is an MHC class II receptor. J. Immunol. 185:23-27.
30. Sato, S., A. S. Miller, M. Inaoki, C. B. Bock, P. J. Jansen, M. L. Tang, and T. F. Tedder. 1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 5:551-562.
31. Zenz, T., D. Mertens, R. Küppers, H. Döhner, and S. Stilgenbauer. 2010. From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat. Rev. Cancer 10:37-50.
32. Del Principe, M. I., G. del Poeta, F. Buccisano, L. Maurillo, A. Venditti, A. Zucchetto, R. Marini, P. Niscola, M. A. Consalvo, C. Mazzone, et al. 2006. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood 108:853-861.
33. Li, F. J., S. Ding, J. Pan, M. A. Shakhmatov, E. Kashentseva, J. Wu, Y. Li, S. J. Soong, N. Chiorazzi, and R. S. Davis. 2008. FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia. Blood 112:179-187.
34. Nuckel, H., C. H. Collins, U. H. Frey, L. Sellmann, J. Durig, W. Siffert, and U. Duhrsen. 2009. FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia. Eur. J. Haematol. 83:541-549.
35. Stamatopoulos, B., B. Haibe-Kains, C. Equeter, N. Meuleman, A. Soree, C. de Bruyn, D. Hanosset, D. Bron, P. Martiat, and L. Lagneaux. 2009. Gene expression profiling based on ZAP70 mRNA expression reveals differences in microenvironment interaction between patients with good and poor prognosis. Haematologica 94:790-799.
36. Nitschke, L. 2005. The role of CD22 and other inhibitory co-receptors in B-cell activation. Curr. Opin. Immunol. 17:290-297.
37. Ravetch, J. V., and L. L. Lanier. 2000. Immune inhibitory receptors. Science 290:84-89.